Amir
Hamzo Dahri, Atta Muhammad Chandio1*, Ali Akbar Rahoo**,
Rafique
Ahmed Memon***
Department of Pathology, *Community Medicine, **Biochemistry and ***Medicine,
Keyword: Nigella Sativa, Serum Cholesterol, Rats
INTRODUCTION
Coronary heart disease (CHD)
has been a global problem since long. It prevails in high class society to low
class society and affects all ages specially the middle age group.1
It is the cause of 25-30% of deaths in most industrialized countries.2
The major cause of CHD is atherosclerosis with reference to major and minor
etiological and pathogenetic factors associated with atherosclerosis,
hyperlipidemic states especially hypercholesterolemia have been under
consideration on a large scale.3 In recent past hyperlipoproteinemia
states have been more discussed regarding the disease entity. High levels of
serum LDL-c with positive and HDL-c with negative correlation pertaining to
atherosclerosis have been found by many workers.4 Diets containing
monounsaturated fatty acids (like olive oil) have been known to increase serum
HDL-c and decrease LDL-c levels.5 Where as polyunsaturated oils
(corn oil) have been referred to decrease both serum LDL-c and HDL-c levels.6
Nigella sativa is
a pretty herb, seeds of which are commonly known as kalonji.7 Its
chemical composition is moisture 7.43%, ash 4.14%, fixed oil 37%, volatile oil
1.64%, albumin 8.2%, mucilage1.9%, organic acid precipitated by copper
0.38%,metarabin 1.36%, melanthin 1.4%, cellulose 8.32%, sugar 2.75%, arabic
acid 3.41% and other substances dissolved by soda 9.38%.8
It was used as powder and
ethanolic extracts in children under 12 years of age for antinematodal and
anticestodal effects and observed significant antinematodal and anticestodal
effects.9
Its ethanolic
extract was used in malignant ulcers of cheek in hospitalized patients and it
healed ulcers. The extract was also used to observe cytotoxic effect in albino
mice and found it as effective cytotoxic agent.10
Its different fractions (extracts)
were used in Rabbits to observe its effects in whole blood clotting and plasma
clot time. In vitro it significantly shortened both and bleeding time, partial
thromboplastin time, prothrombin time and thrombin time in vivo it shortened
bleeding time and partial thromboplastin time but prothrombin time and thrombin
time remained unaffected.11
Its active
principles thymoquinone and polythymoquinone were used in rats, dogs and guinea
pigs to observe its uricosuric, antihistamine and choleratic activity and it
was concluded that it is good uricosuric, strong antihistamine and increased
bile excretion.12
This increased
bile excretion was stimulus, to plan this study to see the effect of Nigella
sativa on serum cholesterol of albino rats.
MATERIAL AND METHODS
Twenty four albino rats of
about eight weeks age, including equal number of males and females were
distributed into two groups of 12 rats each. The animals were numbered and kept
as same sex in iron cages.
The animals were
kept under optimum temperature (24±2OC) and hygienic conditions with
food and water available at all time. A synthetic diet (Table-1) was started
for initial two weeks. The control (D1)and experimental(D2) diets (Table-2)
were started after taking 12-14 hour fasting blood. The other sample was taken
after twenty weeks with same protocol. Both samples were estimated for total
cholesterol, high density lipoprotein cholesterol and low density lipoproteins
cholesterol.
Table 1: Percentage composition of synthetic diet
Ingredients
|
Percentage
|
1. Wheat starch |
62.1 |
2. Casein |
20.0 |
3. Glucose |
10.0 |
4. Choline & methionine |
0.5 |
5. Mineral mixture |
3.5 |
6. Vitamin mixture |
1.0 |
7. Fat |
2.9 |
Ingredients (gm/dl) |
D1
|
D2
|
1. Wheat starch |
62.1 |
62.1 |
2. Casein |
20.0 |
20.0 |
3. Glucose |
10.0 |
10.0 |
4. Choline & methionine |
0.5 |
0.5 |
5. Mineral mixture |
3.5 |
3.5 |
6. Vitamin
mixture |
1.0 |
1.0 |
7. Fat |
2.9 |
2.9 |
8. Kalonji (30mg/kg body wt:) |
- |
+ |
DISCUSSION
Nigella sativa seeds are the common drug
used in Ayurvedic system of medicine through out the world. In a clinical trial
planned to evaluate the hypercholesterolemic activity of the Baraka oil
(kalonji oil) in hypercholesterolemic patients. Seventeen hypercholesterolemic
patients (with mean age of 53years) were administered Baraka oil (2.5ml) in the
morning and evening for four weeks. At the end of trial total cholesterol fell
by 20% to 208mg/dl, LDL cholesterol levels were reduced to 118mg/dl and HDL
cholesterol levels were reduced to 73mg/dl.16
Lowering of the total and LDL cholesterol
will also reduce their ratio with HDL cholesterol, thus reducing the risk for
coronary artery diseases. This could be an important step in the prevention and
management of hypercholesterolemia.
Groups |
Male 0
weeks |
Male 20
weeks |
Female 0
weeks |
Female 20
weeks |
Total 0
weeks |
Total 20
weeks |
Control |
77.10 ± 5.90 |
121.63± 5.16* |
74.45±5.52 |
122.48±3.58* |
75.80±5.63 |
122.06±4.26* |
Exper. |
75.30 ± 5.85 |
119.31± 5.31* |
78.48±7.15 |
115.68±7.80* |
76.9±6.5 |
117.5±6.65* |
P< 0.001 * Highly Significant
Table 4: Comparison of mean HDL-c levels (mg/dl) between 0 to 20 weeks
Groups |
Male 0
weeks |
Male 20
weeks |
Female 0
weeks |
Female 20
weeks |
Total 0
weeks |
Total 20
weeks |
Control |
44.42 ± 6.36 |
80.48± 6.636* |
44.43± 4.12 |
80.47±6.12* |
44.4±5.11 |
80.45±5.95* |
Exper. |
42.77 ± 6.10 |
80.82± 6.88* |
40.17±3.40 |
86.00±3.81* |
41.7±4.9 |
83.42±5.92* |
P< 0.001 * Highly Significant
Groups |
Male 0
weeks |
Male 20
weeks |
Female 0
weeks |
Female 20
weeks |
Total 0
weeks |
Total 20
weeks |
Control |
9.43 ± 2.52 |
14.08± 10.94* |
7.15±3.98 |
13.79±7.71* |
83.0±3.33 |
13.96±9.3* |
Exper. |
9.55 ± 4.70 |
12.59± 8.07* |
15.88±7.71 |
4.43±2.97* |
12.7±6.9 |
8.5±7.8* |
P< 0.001 * Highly Significant
CONCLUSION
On the basis of these findings it is concluded that
nigella sativa produces antiatherogenic effect by decreasing low density
lipoprotein cholesterol level significantly. It also increases high density
lipoprotein cholesterol level. Thus nigella sativa prevents atherogenesis by
decreasing LDL-c.
REFERENCES
1.
National
2.
Park K. Parks text book of
preventive and social medicine. 24th ed.
3.
Ahmed MM, Jeyalingam K, Hassan AM, Marinah T. Dietary fats and
hypercholestrolemia in an experimental model of Macaca Fascilaris. Pak Pathol
1992;3:5-10.
4.
Rader DJ, Ikewaki K, Duverger A. Very low high density lipoproteins
without coronary atherosclerosis. Lancent 1993; 342:1455-8.
5.
Sundram K. High lights of the director general report on palm oil and
human nutrition. Palm oil development 1992;
6.
Shepherd J, Packard CV, Grundy SM. Effects of saturated and polyunsaturated
fat diets on the chemical composition and metabolism of low density
lipoproteins in man. J Lipid Res 1980;21:91-9.
7.
Blatter E, Caius JF,
8.
Saeed HM. Pharmacography Indica Hamdard 1972;
9.
Akhtar MS, Riffat S. Field Trail of saussurea lappa roots against
nematodes and Nigella sativa seed against cestides in children. J Pak Med Assoc
1991;41:185-7.
10. Panikar KR, Salomi MJ, Kesven M, Dorata SR,
Rajgopalam K. Anticancer activity of Nigella sativa. Ancient science of life
1989;8: 262-78.
11. Ghoneim MT, El-Ginly, El-Aami
R, Shouky RE, Yaseen S. Possible effects of some extracts of Negilla sativa
seed on blood coagulation system and Fibrinolytic activity. Proceeding of 2nd
international conference on Islamic medicine,
12. El-Dakhakhany M. Some
pharmacological properties of some constituents of Negilla sativa seed. Planta
Med 1982; 426-8.
13. Le PM,Benhaddou-Andaloussi A,
Settaf A, Cherrah Y, Haddad PS. The petroleum ether extract of Nigella sativa
exerts lipid powering actom in the rats. J Ethanopharmacol. 2004:94(2-3):
251-9.
14. Badary OA, Abdel Nain AB,
Abdel Wahab MH, Hamada FM. Induced hyperlipidermic nephropathy in rats:
Toxicology 2000;143(3):219-26.
15. El Dakha Khani M, Mady NL,
Halim MA. Nigella sativa L. oil protects against induced hepatotoxicity and
improves serum lipid profile in rats. Arzneimittelforschung 2000;50(9);832-6.
_____________________________________________________________________________________________________________________
Address for Correspondence:
Dr. Amir Hamzo Dahri, Department of Pathology,